Clinical Trial: A Study to Compare and Evaluate the Safety, Tolerability and Pharmacokinetics Between DA-5223 and DA-5223-R in Healthy Adult Subjects

U.S., June 7 -- ClinicalTrials.gov registry received information related to the study (NCT07007533) titled 'A Study to Compare and Evaluate the Safety, Tolerability and Pharmacokinetics Between DA-5223 and DA-5223-R in Healthy Adult Subjects' on May 28.

Brief Summary: This study will compare and evaluate the safety, tolerability and pharmacokinetics between DA-5223 and DA-5223-R in healthy adult subjects

Study Start Date: June, 2025

Study Type: INTERVENTIONAL

Condition: Healthy Adult

Intervention: DRUG: DA-5223-R

once a day

DRUG: DA-5223

once a day

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Dong-A ST Co., Ltd.

Disclaimer: Curated by HT Syndication....